In class-action settlement, Minnesota prisoners win access to pricey hepatitis C drugs

Minnesota prisoners with chronic hepatitis C infections must be provided with highly effective but costly antiviral drugs following a class-action lawsuit settlement.

A group of five inmates infected with the virus sued the Department of Corrections in 2015, accusing the agency of withholding the new drugs from them despite the medications having a 95 percent cure rate.

http://www.startribune.com/in-class-action-settlement-minnesota-prisoners-win-access-to-hepatitis-c-drugs/507322252/